These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 6245565)
81. Physiopathology of hereditary polyuric states: a molecular view of renal function. Bichet DG Swiss Med Wkly; 2012; 142():w13613. PubMed ID: 22802123 [TBL] [Abstract][Full Text] [Related]
82. Renal prostaglandin E in renoparenchymal hypertension. Hsieh BS; Chen WY; Yen TS; Hsu HC Taiwan Yi Xue Hui Za Zhi; 1984 Jul; 83(7):627-33. PubMed ID: 6389755 [No Abstract] [Full Text] [Related]
83. [Determining the prostaglandin content of the urine]. Nekrasova AA; Levitskaia IuV; Klembovskiĭ AA Lab Delo; 1982; (2):96-9. PubMed ID: 6174822 [No Abstract] [Full Text] [Related]
84. A family case of nephrogenic diabetes insipidus. Okayasu T; Shigihara K; Kobayashi N; Ishikawa A; Fukushima N; Takase A; Hattori S; Nakajima T; Shishido T; Agatsuma Y Tohoku J Exp Med; 1990 Oct; 162(2):137-45. PubMed ID: 2097813 [TBL] [Abstract][Full Text] [Related]
85. The effect of antidiuretic hormone, indomethacin and naproxen on prostaglandin synthesis of experimentally infected and healthy kidneys. Túri S; Pulkkinen M; Kaihola HL; Kangas L; Nieminen L Int Urol Nephrol; 1982; 14(3):195-200. PubMed ID: 6761298 [TBL] [Abstract][Full Text] [Related]
86. Renal prostaglandin E in sustained severe hypertension. Hsieh BS; Wang TC; Kuo YM; Wu KD; Yen TS; Tsai TJ; Chen WY Taiwan Yi Xue Hui Za Zhi; 1986 Apr; 85(4):329-34. PubMed ID: 3528387 [No Abstract] [Full Text] [Related]
87. Assessment of renal concentrating ability. Curtis JR; Donovan BA Br Med J; 1979 Feb; 1(6159):304-5. PubMed ID: 421089 [TBL] [Abstract][Full Text] [Related]
88. Central, renal and adrenal effects of lithium in man. Miller PD; Dubovsky SL; McDonald KM; Katz FH; Robertson GL; Schrier RW Am J Med; 1979 May; 66(5):797-803. PubMed ID: 443255 [No Abstract] [Full Text] [Related]
89. Csf arginine-vasopressin decreases during dehydration in a patient with post-traumatic diabetes insipidus. Bohnen N; Twijnstra A; Terwel D; Jolles J Horm Metab Res; 1990 Sep; 22(9):508-9. PubMed ID: 2258140 [No Abstract] [Full Text] [Related]
90. Iatrogenic [corrected] extrapontine myelinolysis in central diabetes insipidus: are cyclosporine and 1-desamino-8-D-arginine vasopressin harmful in association? Maghnie M; Genovese E; Lundin S; Bonetti F; Arico M J Clin Endocrinol Metab; 1997 Jun; 82(6):1749-51. PubMed ID: 9177375 [No Abstract] [Full Text] [Related]
91. Familial cases of congenital nephrogenic diabetes insipidus type II: Remarkable increment of urinary adenosine 3',5'-monophosphate in response to antidiuretic hormone. Ohzeki T; Igarashi T; Okamoto A J Pediatr; 1984 Apr; 104(4):593-5. PubMed ID: 6323666 [No Abstract] [Full Text] [Related]
92. The role of renal prostaglandin E as a possible modulator of cyclic AMP production in nephrotic syndrome. Túri S; Havass Z; Bodrogi T Int Urol Nephrol; 1986; 18(3):321-5. PubMed ID: 3021645 [TBL] [Abstract][Full Text] [Related]
94. [Pathogenetic mechanisms of primary arterial hypertension in adolescents]. Markov KhM Ter Arkh; 1979; 51(12):45-56. PubMed ID: 231854 [No Abstract] [Full Text] [Related]
95. [Comparative studies on the activation of the fibrinolytic system by venous stasis and the administration of DDAVP]. Huyke R; Vogel G; Lauten G Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):480-3. PubMed ID: 6083914 [TBL] [Abstract][Full Text] [Related]
96. Is testing with dDAVP useful in detecting carriers of the nephrogenic diabetes insipidus gene? Bichet DG; Arthus MF; Lonergan M Nephron; 1991; 58(3):372-3. PubMed ID: 1896107 [No Abstract] [Full Text] [Related]